Fundraising Fox
Herantis Pharma
Founded 2008 · 25 employees on LinkedIn · 2 known investors
Find your way into Herantis Pharma
Sign up to see every warm intro you have to Herantis Pharma
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Herantis Pharma team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Herantis Pharma is a public pharmaceutical company listed on Nasdaq First North Growth Market Finland, focused on developing therapeutic treatments.
Founders & leadership
AV
Antti VuolantoCEOAntti Vuolanto holds a D.Sc. in Chemistry and has spent over 15 years in biotech leadership roles, including five years as COO and three years as CEO of Herantis Pharma, a Nasdaq-listed pharmaceutical company, alongside prior executive positions at other biotech firms.
Investors · 2
Broadview Ventureslisted by Broadview VenturesBoston
How we know: Broadview Ventures's portfolio page · a partner's Signal profile · Not right? Tell us
In the news
Frequently asked questions
- What does Herantis Pharma do?
- Herantis Pharma is a public pharmaceutical company listed on Nasdaq First North Growth Market Finland, focused on developing therapeutic treatments.
- Who are Herantis Pharma's investors?
- Herantis Pharma's investors include Broadview Ventures, Innovestor Ventures.